Freya Meds Review
Best for: patients wanting dietitian-supported compounded GLP-1 programs
Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo). Includes unlimited doctor consultations, monthly group calls, and dietitian consultation. Claims 450,000+ enrolled.
Medium confidence · Last verified 2026-04-10 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Freya Meds is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Semaglutide (quarterly billing) | compounded | $250 |
| Semaglutide (monthly billing) | compounded | $297 |
| Tirzepatide (quarterly billing) | compounded | $332 |
| Tirzepatide (monthly billing) | compounded | $390 |
✓ Pros
- •Pure GLP-1 specialist — not a multi-category telehealth
- •Price includes unlimited doctor consultations, monthly group calls, and dietitian consultation
- •Both semaglutide and tirzepatide available
- •Multi-month discount on quarterly billing
- •Claims 450,000+ enrolled
✗ Cons
- •No visible LegitScript or PCAB accreditation
- •Pricing is above average ($250–$390/mo) compared to competitors
- •Compounded only — no brand-name options
- •Specific state exclusions not disclosed
Ready to start with Freya Meds?
Starting at $250/month. See current pricing and start your free consultation.
Sources & methodology
Our Freya Meds review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Freya Meds
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Ready to start with Freya Meds?
Starting at $250/month. See current pricing and start your free consultation.